The responses of human adrenocortical cells to stimulation by ACTH(1–24), desacetyl-α-MSH, α-MSH and angiotensin II amide have been compared. Both desacetyl-α-MSH, thought to be the major form of the peptide in the human pituitary and in circulating plasma, and α-MSH caused a significant stimulation of aldosterone, corticosterone and cortisol secretion. Significant stimulation of the production of these steroids was obtained with desacetyl-α-MSH at a concentration of 1 nmol/l, while the response to α-MSH was considerably less sensitive, with a minimum effective concentration of 0·1 μmol/l. These values compared with minimum effective concentrations of 1 pmol/l for ACTH and 0·1 μmol/l for angiotensin II amide. Although cell types were not separated, it is possible to conclude that none of the peptides showed any specificity for the zona glomerulosa, and in each case the same minimum effective concentration of peptide was required for both aldosterone and cortisol secretion. Yields of steroid obtained under conditions of maximal stimulation by ACTH(1–24), α-MSH and desacetyl-α-MSH were at least three to five times the basal output of aldosterone, four to eight times that for corticosterone and more than seven to sixteen times that for cortisol. Angiotensin II amide was a relatively poor stimulant with maximal stimulation only 1·5 × basal. In these experiments the minimum effective concentration for desacetyl-α-MSH (1 nmol/l) was close to the circulating concentration of desacetyl-α-MSH (0·3 nmol/l) in man, and it is thus possible that this peptide may have a physiological role in the control of adrenocortical function.
Journal of Endocrinology (1989) 121, 579–583
Journal of Endocrinology is committed to supporting researchers in demonstrating the impact of their articles published in the journal.
The two types of article metrics we measure are (i) more traditional full-text views and pdf downloads, and (ii) Altmetric data, which shows the wider impact of articles in a range of non-traditional sources, such as social media.
More information is on the Reasons to publish page.
| Sept 2018 onwards | Past Year | Past 30 Days | |
|---|---|---|---|
| Full Text Views | 5 | 1 | 0 |
| PDF Downloads | 2 | 0 | 0 |
Online ISSN: 1479-6805
Print ISSN: 0022-0795
Strengthening biomedical communities
to advance science and health
CONTACT US
Bioscientifica Ltd | Starling House | 1600 Bristol Parkway North | Bristol BS34 8YU | UK
Bioscientifica Ltd | Registered in England no 3190519
